Search
for
Sort by
Research 121–150 of 334
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Developmental origin of polycystic ovary syndrome - a hypothesis
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Ancient-modern concordance in Ayurvedic plants: some examples.
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Adult polycystic ovary syndrome begins in childhood
- Hormonal Therapy for Acne
- Diagnosis of hyperandrogenism: Biochemical criteria
- Pathways to inflammation: acne pathophysiology
- Androgens in women
- Female Hirsutism: Pathophysiological Considerations and Therapeutic Implications*
- Sulfatase inhibitors: a patent review
- Idiopathic Hirsutism*
- Redefining hormone resistance in prostate cancer
- Steroidogenic Isoenzymes in Human Hair and Their Potential Role in Androgenetic Alopecia
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Hormone therapy in acne
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Androgenetic alopecia; drug safety and therapeutic strategies
- Exploring the neural mechanisms of finasteride: a proteomic analysis in the nucleus accumbens
- New lifestyle drugs and somatoform disorders in dermatology
- Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats
- Hirsutism
- Abiraterone and spironolactone in prostate cancer: a combination to avoid
- Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis
- HSD3B1 gene polymorphism and female pattern hair loss in women with polycystic ovary syndrome
- Role of skin enzymes in metabolism of topical drugs
- Hyperadrenocorticism in Ferrets
- A 5α-reductase inhibitor, finasteride, increases differentiation and proliferation of embryonal carcinoma cell-derived-neural cells
- Nonclassic congenital adrenal hyperplasia and the heterozygote carrier